During the CC yesterday, Damaj stated he was confident Fluticare would be approved. He went on to state that the company spent $5 million in acquiring fluticare OTC rights and they did this based on a great deal of confidence.
You'll never know when that PR will come through on approval. I'm sitting pat and waiting out any temporary volatility. You don't want to be on the sidelines when the PR comes through.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.